Table 2 Description of cannabis use behavior stratified by assessment.
From: Symptom trajectories over time by cannabis use status among patients undergoing cancer treatment
Variable | Baseline | Two month | Four month | Six month | ||||
|---|---|---|---|---|---|---|---|---|
% (N) or M (SD) | Overall N | % (N) or M (SD) | Overall N | % (N) or M (SD) | Overall N | % (N) or M (SD) | Overall N | |
Cannabis use | 25.2 (55) | 218 | 24.5 (50) | 204 | 27.1 (54) | 199 | 24.0 (46) | 192 |
Mode of use* | ||||||||
> 1 Mode | 25.5 (14) | 55 | 54.0 (27) | 50 | 51.9 (28) | 54 | 21.7 (10) | 46 |
Smoked | 52.7 (29) | 55 | 46.0 (23) | 50 | 44.4 (24) | 54 | 41.3 (19) | 46 |
Ate | 69.1 (38) | 56.0 (28) | 55.6 (30) | 63.0 (29) | ||||
Drank | 3.6 (2) | 4.0 (2) | 5.6 (3) | 4.4 (2) | ||||
Vaped | 29.1 (16) | 22.0 (11) | 25.9 (14) | 23.9 (11) | ||||
Dabbed | 9.1 (5) | 8.0 (4) | 7.4 (4) | 6.5 (3) | ||||
Dissolved | 10.9 (6) | 6.0 (3) | 13.0 (7) | 19.6 (9) | ||||
Skin | 18.2 (10) | 12.0 (6) | 18.5 (10) | 15.2 (7) | ||||
Other | 14.6 (8) | 12.0 (6) | 3.7 (2) | 10.9 (5) | ||||
CUDIT | ||||||||
CUDIT total (M (SD)) | 5.59 (3.67) | 64 | – | – | – | – | 5.65 (4.87) | 52 |
Non-problematic use (< 8) | 76.6 (49) | – | – | 80.8 (42) | ||||
Hazardous use (8–11) | 18.8 (12) | – | – | 7.7 (4) | ||||
Possible CUD (≥ 12) | 4.7 (3) | – | – | 11.5 (6) | ||||
Cannabis use measures collapsing across time | ||||||||
Any use | 33.0 (72) | 218 | ||||||
Use at > 1 assessment | 26.6 (58) | 218 | ||||||
